Impressive A1c Lowering from Once-Weekly Semaglutide in Type 2 Diabetes By Emma Ryan A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide We recently heard about results from the SUSTAIN 7 trial of semaglutide, a powerful once-weekly, injectable GLP-1 agonist that is currently under FDA review for type 2 diabetes
not in a dramatic way, but enough that I noticed I wasnt waking up as frequently or lying there as long when I did
The starting dose for Wegovy is 0.25 mg per week, and you'll slowly increase the dose every month until you reach the maximum dose of 2.4 mg after five months
Research suggests that protein intake, particularly from sources such as fish, poultry, eggs, and legumes, may increase postprandial GLP-1 secretion
These medications also vary in terms of dosage, strengths, and, you guessed it, cost